BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24670921)

  • 1. Maternal microchimerism in biliary atresia: are maternal cells effector cells, targets, or just bystanders?
    Muraji T
    Chimerism; 2014; 5(1):1-5. PubMed ID: 24670921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal microchimerism in biliary atresia.
    Kobayashi H; Tamatani T; Tamura T; Kusafuka J; Yamataka A; Lane GJ; Kawasaki S; Ishizaki Y; Mizuta K; Kawarasaki H; Gittes GK
    J Pediatr Surg; 2007 Jun; 42(6):987-91; discussion 991. PubMed ID: 17560207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary atresia: graft-versus-host disease with maternal microchimerism as an etiopathogenesis.
    Masuya R; Muraji T; Harumatsu T; Muto M; Nakame K; Nanashima A; Ieiri S
    Transfus Apher Sci; 2022 Apr; 61(2):103410. PubMed ID: 35288054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal microchimerism in patients with biliary atresia: Implications for allograft tolerance.
    Nijagal A; Fleck S; MacKenzie TC
    Chimerism; 2012; 3(2):37-9. PubMed ID: 22772071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evidence of maternal microchimerism in biliary atresia using fluorescent in situ hybridization.
    Hayashida M; Nishimoto Y; Matsuura T; Takahashi Y; Kohashi K; Souzaki R; Taguchi T
    J Pediatr Surg; 2007 Dec; 42(12):2097-101. PubMed ID: 18082716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accumulation of regulatory T cells in the hepatic hilar lymph nodes in biliary atresia.
    Sakamoto N; Muraji T; Ohtani H; Masumoto K
    Surg Today; 2017 Oct; 47(10):1282-1286. PubMed ID: 28293742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Maternal Microchimeric Cells in the Liver of Children With Biliary Atresia.
    Tamaoka S; Fukuda A; Katoh-Fukui Y; Hattori A; Uchida H; Shimizu S; Yanagi Y; Kanaan SB; Sakamoto S; Kasahara M; Yoshioka T; Fukami M
    J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):e83-e86. PubMed ID: 35082246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary atresia: a new immunological insight into etiopathogenesis.
    Muraji T; Suskind DL; Irie N
    Expert Rev Gastroenterol Hepatol; 2009 Dec; 3(6):599-606. PubMed ID: 19929581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological findings for prediction of liver cirrhosis and survival in biliary atresia patients after Kasai procedure.
    Gunadi ; Sirait DN; Budiarti LR; Paramita VMW; Fauzi AR; Ryantono F; Afandy D; Yoshuantari N; Rinonce HT; Makhmudi A
    Diagn Pathol; 2020 Jul; 15(1):79. PubMed ID: 32616059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in the etiopathogenesis of pediatric biliary disease, particularly Caroli's disease with congenital hepatic fibrosis and biliary atresia.
    Nakanuma Y; Harada K; Sato Y; Ikeda H
    Histol Histopathol; 2010 Feb; 25(2):223-35. PubMed ID: 20017109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal microchimerism in underlying pathogenesis of biliary atresia: quantification and phenotypes of maternal cells in the liver.
    Muraji T; Hosaka N; Irie N; Yoshida M; Imai Y; Tanaka K; Takada Y; Sakamoto S; Haga H; Ikehara S
    Pediatrics; 2008 Mar; 121(3):517-21. PubMed ID: 18310200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic overexpression of MHC class II antigens and macrophage-associated antigens (CD68) in patients with biliary atresia of poor prognosis.
    Kobayashi H; Puri P; O'Briain DS; Surana R; Miyano T
    J Pediatr Surg; 1997 Apr; 32(4):590-3. PubMed ID: 9126761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal microchimerism in the livers of patients with biliary atresia.
    Suskind DL; Rosenthal P; Heyman MB; Kong D; Magrane G; Baxter-Lowe LA; Muench MO
    BMC Gastroenterol; 2004 Jul; 4():14. PubMed ID: 15285784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal HLA class I compatibility in patients with biliary atresia.
    Irie N; Muraji T; Hosaka N; Takada Y; Sakamoto S; Tanaka K
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):488-92. PubMed ID: 19590453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique manifestations of biliary atresia provide new immunological insight into its etiopathogenesis.
    Muraji T; Ohtani H; Ieiri S
    Pediatr Surg Int; 2017 Dec; 33(12):1249-1253. PubMed ID: 29022092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic fibrosis and survival in biliary atresia.
    Weerasooriya VS; White FV; Shepherd RW
    J Pediatr; 2004 Jan; 144(1):123-5. PubMed ID: 14722530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocytes buried in the cirrhotic livers of patients with biliary atresia proliferate and function in the livers of urokinase-type plasminogen activator-NOG mice.
    Suemizu H; Nakamura K; Kawai K; Higuchi Y; Kasahara M; Fujimoto J; Tanoue A; Nakamura M
    Liver Transpl; 2014 Sep; 20(9):1127-37. PubMed ID: 24838399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia.
    Tucker RM; Feldman AG; Fenner EK; Mack CL
    J Hepatol; 2013 Oct; 59(4):790-6. PubMed ID: 23685050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia.
    Ohya T; Fujimoto T; Shimomura H; Miyano T
    J Pediatr Surg; 1995 Apr; 30(4):515-8. PubMed ID: 7595823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal microchimerism in health and disease.
    Stevens AM
    Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():121-30. PubMed ID: 26612343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.